Findings are based on a study of 88 men and 78 women with ANCA-associated vasculitis with glomerulonephritis and severe kidney disease at diagnosis.
Patients with vs without ANCA-associated vasculitis are significantly more likely to die after kidney transplantation and to experience postoperative infection. Patients with ANCA-associated ...
Amgen (NASDAQ:AMGN) today announced the presentation of new respiratory data at the American Thoracic Society (ATS) 2024 ...
Patients with GPA were two to three times as likely to experience disease relapse if they scored high on a patient-reported ...
The formation of neutrophil extracellular traps (NETs) is a common feature in the renal glomeruli of patients with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. The use of a DNA repair ...
The formation of neutrophil extracellular traps (NETs) is a common feature in the renal glomeruli of patients with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. The use of a DNA repair ...
The presentation demonstrated positive preclinical data for deoxymabs in the auto-immune disease, anti-neutrophil cytoplasmic antibody (ANCA) vasculitis. Previously, Patrys has shown that its ...
The presentation demonstrated positive preclinical data for deoxymabs in the auto-immune disease, anti-neutrophil cytoplasmic antibody (ANCA) vasculitis. Previously, Patrys has shown that its ...
May 2, 2024 Amgen Inc. beats earnings expectations. Reported EPS is $3.96, expectations were $3.88. Amgen Inc. isn’t one of ...
Amgen AMGN reported first-quarter 2024 adjusted earnings of $3.96 per share, which beat the Zacks Consensus Estimate of $3.76. Earnings declined 1% year over year due to higher operating costs and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results